Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 493  

    Article Cited by others


1 st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23-26, 2011, Zentralklinik Bad Berka, Germany

Baum Richard P, Rösch Frank, Baum Richard P, Rösch Frank

Year : 2011| Volume: 10| Issue : 1 | Page no: 5-6

   This article has been cited by
1 PSMA diagnostics and treatments of prostate cancer become mature
Finn Edler von Eyben,Glenn Stewart Baumann,Richard Paul Baum
Clinical and Translational Imaging. 2018; 6(2): 145
[Pubmed]  [Google Scholar] [DOI]
2 Evaluation of excitation functions of the 68,67,66Zn(p,xn)68,67,66Ga and 67Zn(p,a)64Cu reactions: Validation of evaluated data through comparison with experimental excitation functions of the natZn(p,x)66,67Ga and natZn(p,x)64Cu processes
M.N. Aslam,N. Amjed,S.M. Qaim
Applied Radiation and Isotopes. 2015; 96: 102
[Pubmed]  [Google Scholar] [DOI]
3 Clinical applications of Gallium-68
Sangeeta Ray Banerjee,Martin G. Pomper
Applied Radiation and Isotopes. 2013; 76: 2
[Pubmed]  [Google Scholar] [DOI]
4 Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results
R Schoffelen,O C Boerman,D M Goldenberg,R M Sharkey,C M L van Herpen,G M Franssen,W J McBride,C-H Chang,E A Rossi,W T A van der Graaf,W J G Oyen
British Journal of Cancer. 2013; 109(4): 934
[Pubmed]  [Google Scholar] [DOI]


Read this article